A detailed history of Rise Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 97 shares of UTHR stock, worth $43,546. This represents 0.02% of its overall portfolio holdings.

Number of Shares
97
Previous 95 2.11%
Holding current value
$43,546
Previous $27,000 48.15%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

BUY
$274.7 - $438.75 $549 - $877
2 Added 2.11%
97 $40,000
Q1 2025

May 15, 2025

SELL
$304.42 - $380.78 $13,090 - $16,373
-43 Reduced 31.16%
95 $29,000
Q1 2024

Apr 09, 2024

BUY
$210.76 - $249.51 $29,084 - $34,432
138 New
138 $31,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $20.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.